XT
PPH icon

XTX Topco’s VanEck Pharmaceutical ETF PPH Stock Holding History

XTX Topco’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$937K Buy
8,567
+2,452
+40% +$254K 0.01% 1851
2026
Q1 		$635K Buy
+6,115
New +$651K 0.01% 1807
2025
Q4 		– Sell
-4,391
Closed -$397K – 3685
2025
Q3 		$397K Buy
+4,391
New +$385K 0.02% 1265

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

XTX Topco's PPH Position: Q2 2026 in Review

XTX Topco increased its VanEck Pharmaceutical ETF (PPH) stake by 40% in Q2 2026, buying an estimated $254K and bringing the position to 8,567 shares worth $937K. The position accounts for 0.01% of the portfolio, ranked #1851.

XTX Topco first reported a position in PPH in Q3 2025 and has held it in 3 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • XTX Topco held 8,567 shares of VanEck Pharmaceutical ETF worth $937K as of Q2 2026.
  • XTX Topco bought 2,452 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $254K.
  • VanEck Pharmaceutical ETF made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1851 holding.
  • XTX Topco first reported a position in VanEck Pharmaceutical ETF in Q3 2025 and has held it in 3 quarters since.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.